The 2020/21 RUP programme will be supported by the Pathway Transformation Fund (PTF) – Phase three

The Pathway Transformation Fund (PTF) helps NHS organisations integrate the three eligible Rapid Uptake Products into everyday practices. These are:

  • FeNO – Diagnostic test for asthma
  • Asthma Biologics – Medication for severe asthma
  • Lipid Optimisation project – Driving effective management of cardiovascular disease (CVD)


The application cycle for these products closed in April 2021 and in June 2021 it was announced that 51 projects worth almost £2.8 million will receive support.

PTF will support projects to overcome barriers to deploying products, such as:

  • training staff to use new equipment
  • pathway redesign
  • providing specialist nurses/clinical staff needed to implement a new part of the procedure
  • covering double running costs
  • establishing new data collection methods.


Pathway Transformation Fund FAQ